Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketogenic Diet with Chemo-Radiation for Newly Diagnosed GBM
NCT02046187Phase 2Terminated
- Sponsor
- St. Joseph's Hospital and Medical Center
- Start
- Oct 2013
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in glioblastoma (GBM), sponsored by St. Joseph's Hospital and Medical Center. Primary endpoint: Ketogenic diet tolerance and compliance at 8 weeks. Started Oct 2013; status: terminated.
02
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT02046187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02046187.